{'fraction_non_alphanumeric': 0.03206412825651302, 'fraction_numerical': 0.03406813627254509, 'mean_word_length': 5.4935064935064934, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
TPPP3 inhibits the proliferation, invasion and migration of endometrial carcinoma targeted with miR‐1827

Database screening indicated that tubulin polymerization‐promoting protein 3 (TPPP3) was involved in pathogenesis of multiple cancer types. miR‐1827 has a potential role in a variety of human cancers. However, the role of TPPP3 and its underlying molecular mechanism in endometrial cancer (EC) has not been investigated. Herein, we aimed to reveal the role of TPPP3/miR‐1827 in EC progression.